Marginal Zone Lymphoma (MZL): Chronic Immune Stimulation, Heterogeneity and Beyond
11h agoen
Source
OncoDailyMarginal Zone Lymphoma (MZL): Chronic Immune Stimulation, Heterogeneity and Beyondoncodaily.comMarginal zone lymphoma (MZL) is the second most common indolent B-cell non-Hodgkin lymphoma. It is the prototype of an antigen-associated malignancy, with clear examples in which removal of the inciting […]
You might also wanna read

Pan-cancer AI atlas reveals diversity and spatial organization of tertiary lymphoid structures in tumors
Researchers built a pan-cancer atlas of tertiary lymphoid structures (TLSs) in human tumors, developing an AI-based framework to detect and
Researchers identify biological markers of treatment-resistant aggressive lymphoma
Researchers from Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified biological features that distinguish particul
Spain confirms 111 cases of rare breast implant-associated lymphoma
The Spanish Agency of Medicines and Medical Devices (Aemps) has confirmed 111 cases of anaplastic large cell lymphoma (ALCL) associated with
Spain confirms 111 cases of rare breast implant-associated lymphoma
The Spanish Agency of Medicines and Medical Devices (Aemps) has confirmed 111 cases of anaplastic large cell lymphoma (ALCL) associated with
The Evolving Role of Targeted Therapies in Chronic Lymphocytic Leukemia Care
ltcnews.com·12d ago
New antibody shows promise for blocking Epstein-Barr virus linked to cancer and autoimmune disease
Epstein-Barr virus (EBV) is carried by 95% of people, usually lying dormant but linked to serious diseases like multiple sclerosis, lupus, r
SEZ6-targeting antibody−drug conjugate ABBV-706 in advanced small cell lung cancer and solid tumors: a phase 1 trial
doi.org·5d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.